Expert Interview
A Second Look: Discussing the treatment landscape and the potential of nipocalimab, an investigational drug for the treatment of Sjögren's syndrome along with the positive topline results from the Phase 2 DAHLIAS study
Ticker(s): JNJInstitution: Allergy & Arthritis Associates
- Practicing rheumatology in Morris County for over 20 years
- Founding Fellow of the American College of Rheumatology
- Principal investigator in over 30 studies on new treatments for rheumatoid arthritis, osteoarthritis, systemic lupus and osteoporosis and lectures frequently on these topics
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
